Catalyst Pharmaceutical Partners (CPRX) PT Lowered to $4.50 at Roth Capital
Tweet
Share
E-mailGet Alerts CPRX Hot Sheet
Price: $31.49 --0%
Rating Summary:
7 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 9 | New: 26
Rating Summary:
7 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 9 | New: 26
Join SI Premium – FREE
Roth Capital analyst Scott Henry lowered the price target on Catalyst Pharmaceutical Partners (NASDAQ: CPRX) to $4.50 (from $7.00) while maintaining a Buy rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Securitize Corp (SECZ) PT Raised to $12 at StoneX on 'Innovation Exemption'
- China Cinda Asset Management (1359:HK) PT Lowered to HK$0.95 at JPMorgan
- TIME dotCom Berhad (TDC:MK) PT Raised to MYR7.50 at JPMorgan
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Roth CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
